The Effects of Yoga Practice on Exercise Capacity, Arterial Stiffness, Respiratory Function, Peripheral Muscle Strength, Posture and Quality of Life in Children With Cystic Fibrosis

November 5, 2026 updated by: Naciye Vardar-Yagli, Hacettepe University

The aim of this study is to investigate the effects of exercise training applied through telerehabilitation on exercise capacity, peripheral and respiratory muscle strength, arterial stiffness, posture and quality of life in children with cystic fibrosis.

Study Overview

Detailed Description

The most common problems in patients with cystic fibrosis (CF) are increased bronchial secretions, reduced exercise tolerance and shortness of breath.

Exercise capacity is limited due to muscle dysfunction, inflammation and progressive respiratory disease. Cardiovascular complications are one of the long-term complications of CF. Increased arterial stiffness is an indicator of elevated cardiovascular risk. It has been shown that patients with CF have increased arterial stiffness compared to their healthy peers.

Exercise training has a positive effect on exercise capacity, respiratory function and quality of life in patients with CF. Studies have shown that exercise training applied using the telerehabilitation method increases exercise capacity and improves peripheral muscle function in patients with CF. Peripheral muscle function, functional capacity, arterial stiffness and posture have been assessed in patients with CF. Furthermore, studies have been performed on patients with CF involving exercise training via telerehabilitation.In addition, various studies have shown that yoga and aerobic exercise training have positive effects on arterial stiffness. Although there are only a few studies involving patients with CF who practise yoga, no study has been found that assesses the effects of yoga practise via telerehabilitation on exercise capacity, peripheral and respiratory muscle function, and arterial stiffness.The purpose of this study is to examine the effects of exercise training using telerehabilitation on exercise capacity, peripheral and respiratory muscle strength, arterial stiffness, posture and quality of life in children with CF.

Children were randomly assigned to three groups: The first group will receive online aerobic exercise training and yoga sessions. The second group will receive only aerobic exercise training.The third group will be informed about the importance of physical activity and will be given recommendations for physical activity. Participants' respiratory function, exercise capacity, arterial stiffness parameters, peripheral muscle function, posture and quality of life questionnaire will be evaluated initially and following an 8-week exercise programme.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 8-18 years with a diagnosis of cystic fibrosis (CF)
  • Access to online exercise training
  • Percent predicted of forced expiratory volume at one second (FEV1) > 40% in pulmonary function test

Exclusion Criteria:

  • Being diagnosed with acute pulmonary exacerbation at the time of study and /or within the last month.
  • Being physically or perceptually competent to exercise
  • Patients with allergic bronchopulmonary aspergillosis who were treated with systemic steroid therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Combined Group

aerobic exercise training and yoga sessions in patients with cystic fibrosis

Patients will be performed online in groups of 3-4 participants supervised aerobic exercises and yoga sessions. Aerobic exercises will be applied for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week, on the days when yoga sessions are not performed. The yoga sessions will consist of 30-40-minute sessions, with three sessions per week for eight weeks. The yoga sessions will consist of three core components - asana (postures), pranayama (breathing) and meditation (focus).

Experimental: aerobic group

only aerobic exercises in patients with cystic fibrosis

Patients will be performed online in groups of 3-4 participants supervised only aerobic exercises Aerobic exercises will be applied for 8 weeks, for 30-45 minutes, at 65-75% of the maximum heart rate, 3 days a week.

Experimental: control group

physical activity recommendations in patients with cystic fibrosis

Patients will be informed of the benefits of physical activity and appropriate physical activity recommendations will be provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
six minute walk test
Time Frame: before the exercise training

the distance reached in the six-minute walk test

before the exercise training
six minute walk test
Time Frame: eigth week

the distance reached in the six-minute walk test

eigth week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial stiffness
Time Frame: before the exercise training

Arterial stiffness will be assessed non-invasively using the Mobil-O-GRAPH (I.E.M., Stolberg, Germany).

before the exercise training
Arterial stiffness
Time Frame: eight week

Arterial stiffness will be assessed non-invasively using the Mobil-O-GRAPH (I.E.M., Stolberg, Germany).

eight week
Respiratory muscle strength
Time Frame: before the exercise training

Respiratory muscle strength will be evaluated using mouth pressure device

before the exercise training
Respiratory muscle strength
Time Frame: eight week

Respiratory muscle strength will be evaluated using mouth pressure device

eight week
respiratory muscle endurance
Time Frame: before the exercise training

Respiratory muscle endurance will be assessed using constant load test

before the exercise training
respiratory muscle endurance
Time Frame: eight week

Respiratory muscle endurance will be assessed using constant load test

eight week
Pulmonary functions-FVC
Time Frame: before the exercise training

Forced vital capacity (FVC)

before the exercise training
Pulmonary functions-FVC
Time Frame: eight week

Forced vital capacity (FVC)

eight week
Pulmonary functions-FEV1
Time Frame: before the exercise training

Forced expiratory volume in the first second (FEV1)

before the exercise training
Pulmonary functions-FEV1
Time Frame: eigth week

Forced expiratory volume in the first second (FEV1)

eigth week
Pulmonary functions-FEV1/FVC
Time Frame: before the exercise training

FEV1/ FVC

before the exercise training
Pulmonary functions-FEV1/FVC
Time Frame: eight week

FEV1/ FVC

eight week
Pulmonary functions-FEF25-75
Time Frame: before the exercise training

Forced mid-expiratory flow (FEF25-75)

before the exercise training
Pulmonary functions-FEF25-75
Time Frame: eigth week

Forced mid-expiratory flow (FEF25-75)

eigth week
Peripheral muscle strength
Time Frame: before the exercise training

Peripheral muscle strength will be assessed using dynamometer

before the exercise training
Peripheral muscle strength
Time Frame: eigth week

Peripheral muscle strength will be assessed using dynamometer

eigth week
1 minute sit to stand test (STS) repetitions
Time Frame: before the exercise training

number of sit to stand for one minute is recorded

before the exercise training
1 minute sit to stand test (STS) repetitions
Time Frame: eight week

number of sit to stand for one minute is recorded

eight week
posture
Time Frame: before the exercise training

Posture will be assessed using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent,1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent(0-2), very good (3-4), good (5-7), fair (8-11)and poor (>12).

before the exercise training
posture
Time Frame: eigth week

Posture will be assessed using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent,1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent(0-2), very good (3-4), good (5-7), fair (8-11)and poor (>12).

eigth week
Quality of life assessment
Time Frame: before the exercise training

Quality of life will be assessed using the Cystic Fibrosis Questionnaire-Revised .The Cystic Fibrosis Questionnaire-Revised is a disease-specific health-related quality of life measure for children, adolescents with cystic fibrosis (CF). The questionnaire evaluate physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment,respiratory symptoms and digestive symptoms. Score range is 0-100. Higher scores indicating higher health-related qualityof life.

before the exercise training
Quality of life assessment
Time Frame: eigth week

Quality of life will be assessed using the Cystic Fibrosis Questionnaire-Revised .The Cystic Fibrosis Questionnaire-Revised is a disease-specific health-related quality of life measure for children, adolescents with cystic fibrosis (CF). The questionnaire evaluate physical functioning, emotional functioning, social functioning, body image, eating disorders, treatment,respiratory symptoms and digestive symptoms. Score range is 0-100. Higher scores indicating higher health-related quality of life.

eigth week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Naciye Vardar-Yagli, PhD, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2025

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

November 5, 2026

First Submitted That Met QC Criteria

November 5, 2026

First Posted (Actual)

November 12, 2026

Study Record Updates

Last Update Posted (Actual)

November 12, 2026

Last Update Submitted That Met QC Criteria

November 5, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe